Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Dual Function Found for mRNA Modifier
Scientific Advances

Dual Function Found for mRNA Modifier

By Will DossJul 5, 2022
Share
Facebook Twitter Email
Daniel Arango, PhD, assistant professor of Pharmacology, was lead author of the study published in the journal Molecular Cell.
Daniel Arango, PhD, assistant professor of Pharmacology, was lead author of the study published in the journal Molecular Cell.

A chemical modification of messenger RNA (mRNA) performs different functions depending on its location, according to a study published in the journal Molecular Cell.

This modification is produced by NAT10, an enzyme overexpressed in some cancers, so understanding how it modifies protein expression could lead to breakthroughs in the future, according to Daniel Arango, PhD, assistant professor of Pharmacology and lead author of the study.

“We don’t yet know if the role of the enzyme in promoting cancer growth is directly related to its mRNA modification, but that’s a future question of ours,” Arango said.

Genetic information is converted from genes into proteins with the help of mRNA, and chemical modifications of RNA are a major regulator of this process. These modifications can change the fate of an mRNA, according to Arango.

“I think of it like an alphabet — the letters are static, but you can combine those letters into words and modify those words with accents,” Arango said. “These modifications are genomic accents: they change the meaning of the genomic alphabet.”

Regions of mRNA encode for proteins alongside non-coding regions that have regulatory function. Most of these modifications operate by methylation but one modification works through acetylation: cytidine acetylation (ac4C). In the current study, investigators used genetically modified cells to study how the ac4C modification impacts gene expression.

The scientists found that the specific position of ac4C was important; ac4C in the coding region promotes more efficient translation, contributing to eventual upregulation of the protein that’s being expressed. On the other hand, if ac4C is in the non-coding region — specifically, near an mRNA translation initiation site — it interferes with recognition of those sites, and decreases translation and subsequent protein expression.

Increased expression of the enzyme NAT10 is associated with some cancers such as acute myeloid leukemia and hepatocellular carcinoma. The dual function of ac4C could be related, but more investigation is required, according to Arango.

“How this duality is implicated in rampant cell proliferation is unknown, but this is something we will study in the future,” Arango said. “This could also potentially be harnessed to manipulate protein production in biotechnology or clinical settings.”

Arango is a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

This study was supported by National Cancer Institute grant K99/R00 R00CA245035 and the Intramural Research Program of NIH, Center for Cancer Research, National Cancer Institute.

Cancer Genetics Pharmacology Research
Share. Facebook Twitter Email

Related Posts

Using Gene Expression to Predict if a Brain Tumor is Likely to Grow Back

Nov 29, 2023

Immigrants Living in the U.S. Have Fewer Preterm Births

Nov 28, 2023

Feinberg Investigators Recognized on 2023 ‘Highly-Cited’ List

Nov 27, 2023

Comments are closed.

Latest News

Using Gene Expression to Predict if a Brain Tumor is Likely to Grow Back

Nov 29, 2023

Immigrants Living in the U.S. Have Fewer Preterm Births

Nov 28, 2023

Feinberg Investigators Recognized on 2023 ‘Highly-Cited’ List

Nov 27, 2023

Aortic Valve Replacement Procedures Show Similar Long-Term Survival Rates  

Nov 27, 2023

New Human Gene Cluster Sequence Discovered

Nov 22, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
2023-Sim-Open-House_161
2023-Sim-Open-House_127
2023-Sim-Open-House_108
2023-Sim-Open-House_106
2023-Sim-Open-House_118
2023-Sim-Open-House_068
2023-Sim-Open-House_069
2023-Sim-Open-House_027
2023-Sim-Open-House_155
2023-Sim-Open-House_161
2023-Sim-Open-House_127
2023-Sim-Open-House_108

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.